Onglyza is a medication prescribed to Type-2 diabetes patients. The particular benefit of Onglyza is that it helps regulate blood sugar levels with no increased risk of hypoglycemia (low blood sugar). Such medications are an important component to many diabetes treatment plans, which is why they are prescribed so often. However, recent studies indicate that patients taking Onglyza may have an increased risk of serious health conditions, such as pancreatic cancer, thyroid cancer, and heart failure.
Links to these serious health conditions were discovered as early as 2013 by the New England Journal of Medicine and investigated by the FDA. Given these studies, it would seem reasonable for the manufacturer to pull this potentially harmful medication from pharmacy shelves, but that’s not the case. Since the discovery of these health risks, thousands of patients across the U.S. have taken Onglyza to treat their Type-2 diabetes, putting their lives at risk.
If you or someone you love suffered heart failure or was diagnosed with thyroid or pancreatic cancer after taking Onglyza, call our drug injury lawyers today for a free evaluation of your claim. You may be entitled to significant compensation for your injuries, but your ability to seek damages is limited, so call us today.